Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124827492 | 12482749 | 2 | F | 20160822 | 20160620 | 20160824 | EXP | US-PFIZER INC-2016304036 | PFIZER | 59.00 | YR | F | Y | 0.00000 | 20160824 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124827492 | 12482749 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 300 MG, 1X/DAY (150 MG X2) | U | 20699 | 300 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 124827492 | 12482749 | 2 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | 50 MG, 1-2 AT BEDTIME | 0 | TABLET | ||||||||||
| 124827492 | 12482749 | 3 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 5 MG, 1X/DAY (AT BEDTIME) | 0 | 5 | MG | TABLET | QD | |||||||
| 124827492 | 12482749 | 4 | C | BENZTROPINE MESYLATE. | BENZTROPINE MESYLATE | 1 | 0.5 DF, 1X/DAY (2 MG TABLET, HALF AT BEDTIME) | 0 | .5 | DF | TABLET | QD | |||||||
| 124827492 | 12482749 | 5 | C | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | 400 MG, 1X/DAY (AT BEDTIME) | 0 | 400 | MG | PROLONGED-RELEASE TABLET | QD | |||||||
| 124827492 | 12482749 | 6 | C | NOVOLOG | INSULIN ASPART | 1 | 1 IU, UNK (FOR EVERY 10 CARBS) | 0 | 1 | IU | |||||||||
| 124827492 | 12482749 | 7 | C | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | 20 MG, DAILY | 0 | 20 | MG | TABLET | ||||||||
| 124827492 | 12482749 | 8 | C | LANTUS | INSULIN GLARGINE | 1 | 18 IU, 2X/DAY (18 UNITS IN THE AM AND 18 UNITSAT HS) | 0 | 18 | IU | BID | ||||||||
| 124827492 | 12482749 | 9 | C | DEPAKOTE | DIVALPROEX SODIUM | 1 | 750 MG, 1X/DAY (AT BEDTIME) (500 AND 250) | 0 | 750 | MG | PROLONGED-RELEASE TABLET | QD | |||||||
| 124827492 | 12482749 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 200 UG, DAILY | 0 | 200 | UG | |||||||||
| 124827492 | 12482749 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 2000 IU, DAILY | 0 | 2000 | IU | |||||||||
| 124827492 | 12482749 | 12 | C | NIACIN. | NIACIN | 1 | 500 MG, DAILY | 0 | 500 | MG | |||||||||
| 124827492 | 12482749 | 13 | C | FISH OIL | FISH OIL | 1 | 1000 MG, 2X/DAY | 0 | 1000 | MG | BID | ||||||||
| 124827492 | 12482749 | 14 | C | ASPRIN | ASPIRIN | 1 | 81 MG, DAILY | 0 | 81 | MG | |||||||||
| 124827492 | 12482749 | 15 | C | ZOCOR | SIMVASTATIN | 1 | 40 MG, DAILY | 0 | 40 | MG | |||||||||
| 124827492 | 12482749 | 16 | C | TAMOXIFEN CITRATE. | TAMOXIFEN CITRATE | 1 | 10 MG, 2X/DAY | 0 | 10 | MG | BID | ||||||||
| 124827492 | 12482749 | 17 | C | OXYBUTYNIN CHLORIDE. | OXYBUTYNIN CHLORIDE | 1 | 10 MG, DAILY | 0 | 10 | MG | |||||||||
| 124827492 | 12482749 | 18 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 25 MG, 2X/DAY | 0 | 25 | MG | BID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124827492 | 12482749 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124827492 | 12482749 | Dyskinesia | |
| 124827492 | 12482749 | Insomnia | |
| 124827492 | 12482749 | Parkinsonism | |
| 124827492 | 12482749 | Prescribed overdose | |
| 124827492 | 12482749 | Schizoaffective disorder | |
| 124827492 | 12482749 | Tardive dyskinesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |